Skip to Main Content

VPS - Variant Priority Score Current genetic-testing tools (ClinVar, InterVar, Franklin) can only classify variants that already exist in reference databases - roughly 80% of which are European-ancestry. For the 2 billion people of South Asian descent, most clinically relevant variants are novel: never seen, never classified, never scored. A "negative" report is often not truly negative - it is uninformative. We built VPS, a phenotype-driven, population-aware, inheritance-aware engine that scores exactly these novel and uncertain-significance variants. A clinician starts from a clinical question, not a gene list; VPS assembles the relevant gene panel, then scores every variant on five transparent axes , pathogenicity (blending the ESM-2 protein language model, the Evo2 DNA language model, and REVEL/AlphaMissense/CADD), inheritance-aware population frequency (Whiffin–Ware maximum credible allele frequency), domain criticality, regional pathogenic density, and AlphaFold structural confidence , into a single 0–100 priority with a plain-English rationale for each variant. Crucially, the frequency axis is inheritance-specific: the same allele can score consistent with a recessive disease yet be far too common for a dominant one, so every panel is split by inheritance model. Applied to IndiGenomes (1,029 open-source Indian whole genomes, CSIR-IGIB), we scored 3,594 novel variants , absent from every global database , across 6 inheritance panels and 52 genes spanning Wilson disease, sudden cardiac death (recessive and dominant), primary immunodeficiency/HLH, treatable neurometabolic disease, and hereditary breast/ovarian cancer, at 100% coverage across all variant classes (missense, truncating, in-frame indel, and non-coding). As blinded validation, known ClinVar Pathogenic/Likely-Pathogenic variants scored measurably higher than known Benign variants (Wilson: 64.3 vs 57.9) without ClinVar labels ever being used as scoring input — the separation comes purely from independent evidence. This matters because every one of these 3,594 variants sits in a gene where a missed variant can mean a preventable death , a homozygous cardiac variant in a child, a treatable neurometabolic disorder with a closing therapeutic window, a hereditary-cancer variant invisible to a European-calibrated panel. VPS is a framework for ethnicity-aware variant interpretation: same data, same patient, a different and defensible answer, because it scores what other tools call negative. (Research-triage tool it ranks which variants warrant functional follow-up, not a clinical diagnostic.)

Team

29-2004

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview